Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | ENO3 |
| Upstream (Parents) |
|---|
| (<<) CASP8 → ENO3 |
| (<<) DYRK1A → ENO3 |
| (<<) FAS → ENO3 |
| (<<) GNB2L1 → ENO3 |
| (<<) GSK3A → ENO3 |
| (<<) GYPC → ENO3 |
| (<<) HOPX → ENO3 |
| (<<) ID1 → ENO3 |
| (<<) ITGB1 → ENO3 |
| (<<) KLHDC5 → ENO3 |
| (<<) LCP1 → ENO3 |
| (<<) NDOR1 → ENO3 |
| (<<) PPP1R3B → ENO3 |
| (<<) PRKACB → ENO3 |
| (<<) SEMA3A → ENO3 |
| (<<) SLC34A3 → ENO3 |
| (<<) SP3 → ENO3 |
| (<<) TMPRSS11D → ENO3 |
| (<<) TRAF2 → ENO3 |
| (<<) TXNIP → ENO3 |
| Downstream (Children) |
|---|
| ENO3 → ETS1 (>>) |
| ENO3 → MYO1E (>>) |
| ENO3 → NFKBIB (>>) |
| ENO3 → RARB (>>) |
| ENO3 → RBM7 (>>) |
| ENO3 → RCOR2 (>>) |
| ENO3 → ZNF461 (>>) |
